Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
Osama Sabri(Klinik und Poliklinik für Nuklearmedizin), James W. Ironside(MRC Centre for Regenerative Medicine), Katrin Roth(Bayer (Germany)), Anja Hoffmann(Helmholtz-Zentrum Dresden-Rossendorf), Andrew Stephens(Piramal (Germany)), Christopher C. Rowe(The University of Melbourne), Shigeo Murayama(Tokyo Metropolitan Institute of Gerontology), Henryk Barthel(Leipzig University), John Seibyl(Elucid Bioimaging), Yasuomi Ouchi(Hamamatsu Photonics (Japan)), Hiroyasu Akatsu(Fukushimura Hospital), Bernardino Ghetti(Indiana University School of Medicine), James B. Leverenz(University of Washington), Walter Schulz‐Schaeffer(Saarland University), Thomas G. Beach(Banner Sun Health Research Institute), André Mueller(Piramal (Germany)), Kenji Ishii(Tokyo Metropolitan Institute of Gerontology), Cornelia Reininger(Bayer (Germany)), Masaki Takao(National Center of Neurology and Psychiatry), Marwan N. Sabbagh(Cleveland Clinic), Ana M. Catafau(Piramal (Germany)), Norman Koglin(Piramal (Germany)), Kohei Senda(Toyota Kosei Hospital)
Cited by 605
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k